45 | | - | [ Oklahoma Medical Marijuana and Patient Protection |
---|
46 | | - | Act - inclusion of expiration or use by dates - |
---|
47 | | - | emergency ] |
---|
48 | | - | |
---|
49 | | - | |
---|
| 40 | + | An Act relating to medical marijuana; amending 63 |
---|
| 41 | + | O.S. 2021, Section 427.18, which re lates to the |
---|
| 42 | + | Oklahoma Medical Marijuana and Patient Protection |
---|
| 43 | + | Act; requiring the inclusion of expiration or use by |
---|
| 44 | + | dates; directing the Oklahoma Medical Marijuan a |
---|
| 45 | + | Authority to promulgate rules; and declaring an |
---|
| 46 | + | emergency. |
---|
50 | 47 | | |
---|
51 | 48 | | |
---|
52 | 49 | | |
---|
53 | 50 | | BE IT ENACTED BY THE P EOPLE OF THE STATE OF OKLAHOMA: |
---|
54 | 51 | | SECTION 1. AMENDATORY 63 O.S. 2021, Section 427.18, is |
---|
55 | 52 | | amended to read as follows: |
---|
56 | 53 | | Section 427.18 A. An Oklahoma medical marijuana business sha ll |
---|
57 | 54 | | not sell, transfer or otherwise distribute medical marijuana or |
---|
58 | 55 | | medical marijuana product t hat has not been packaged and labeled in |
---|
59 | 56 | | accordance with this sec tion and rules promulgated by the State |
---|
60 | 57 | | Commissioner of Health. |
---|
61 | 58 | | B. A medical marijuana dispensa ry shall return medical |
---|
62 | 59 | | marijuana and medical marijuan a product that does not meet packaging |
---|
63 | 60 | | or labeling requirements in this section or rules promulgated |
---|
64 | 61 | | pursuant thereto to the entity who transferred it to the dispensary . |
---|
93 | 89 | | returned, what was returned and the date of the return or dispose of |
---|
94 | 90 | | any usable marijuana that does not meet these require ments in |
---|
95 | 91 | | accordance with the Oklahoma Medical Marijuana and Patient |
---|
96 | 92 | | Protection Act. |
---|
97 | 93 | | C. 1. Medical marijuana packaging shall be packaged to |
---|
98 | 94 | | minimize its appeal to children and shall not depi ct images other |
---|
99 | 95 | | than the business name logo of the medical mariju ana producer and |
---|
100 | 96 | | image of the product. |
---|
101 | 97 | | 2. A medical marijuana business shall not place any co ntent on |
---|
102 | 98 | | a container in a manner that reasonably appears to target |
---|
103 | 99 | | individuals under the age of t wenty-one (21) including, but not |
---|
104 | 100 | | limited to, cartoon characters or similar images. |
---|
105 | 101 | | 3. Labels on a container shall not include any false or |
---|
106 | 102 | | misleading statements. |
---|
107 | 103 | | 4. No container shall be intentionally or knowingl y labeled so |
---|
108 | 104 | | as to cause a reasonable pat ient confusion as to whether the medical |
---|
109 | 105 | | marijuana, medical marij uana concentrate or medical marijuana |
---|
110 | 106 | | product is a trademarked product or labeled in a manne r that |
---|
111 | 107 | | violates any federal trademark law or regulation. |
---|
112 | 108 | | 5. The label on the container shall not m ake any claims |
---|
113 | 109 | | regarding health or physical benefits to the patie nt. |
---|
144 | 139 | | 7. If the medical marijuana product is perishable, the label on |
---|
145 | 140 | | the container of the product shall include a maximum six-month |
---|
146 | 141 | | expiration date or a use by date if the medical marijuana product |
---|
147 | 142 | | has not undergone stability testing. By November 1, 2022, the |
---|
148 | 143 | | Authority shall promulgate rules establishing stability testing |
---|
149 | 144 | | standards and requirements. |
---|
150 | 145 | | D. The State Department of Health shall develop minimum |
---|
151 | 146 | | standards for packaging and labeling of medical marijuana and |
---|
152 | 147 | | medical marijuana products. Such standards shall include, but not |
---|
153 | 148 | | be limited to, the required contents of labels to be affixed to all |
---|
154 | 149 | | medical marijuana and medical marijuana products prior to transfer |
---|
155 | 150 | | to a licensed patient or caregiver, which shall include, at a |
---|
156 | 151 | | minimum: |
---|
157 | 152 | | 1. THC and other cannabinoid potency, and terpenoid potency; |
---|
158 | 153 | | 2. A statement indicating that the product has been tested for |
---|
159 | 154 | | contaminants; |
---|
160 | 155 | | 3. One or more product warnings to be determined by the |
---|
161 | 156 | | Department; and |
---|
162 | 157 | | 4. Any other information the Department deems necessary. |
---|
163 | 158 | | SECTION 2. It being immediately necessary for the preservation |
---|
164 | 159 | | of the public peace, health or safety, an emergency is hereby |
---|
192 | | - | declared to exist, by r eason whereof this act shall take effect and |
---|
193 | | - | be in full force from and after its passage and approval. |
---|
194 | | - | COMMITTEE REPORT BY: COMMITTEE ON HEALTH AND HUMAN SERVICES |
---|
195 | | - | April 11, 2022 - DO PASS AS AMENDED |
---|
| 188 | + | Passed the House of Representatives the 23rd day of March, 2022. |
---|
| 189 | + | |
---|
| 190 | + | |
---|
| 191 | + | |
---|
| 192 | + | |
---|
| 193 | + | Presiding Officer of the House |
---|
| 194 | + | of Representatives |
---|
| 195 | + | |
---|
| 196 | + | |
---|
| 197 | + | Passed the Senate the ___ day of __________, 2022. |
---|
| 198 | + | |
---|
| 199 | + | |
---|
| 200 | + | |
---|
| 201 | + | |
---|
| 202 | + | Presiding Officer of the Senate |
---|
| 203 | + | |
---|
| 204 | + | |
---|